Eligard Stungulyfsstofn og leysir, lausn 7,5 mg Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 7,5 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 7,5 mg

Eligard Stungulyfsstofn og leysir, lausn 45 mg Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 45 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 45 mg

Eligard Stungulyfsstofn og leysir, lausn 22,5 mg Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 22,5 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 22,5 mg

Arexvy Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

arexvy

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - sýkingar af völdum sýklalyfja - bóluefni - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur.

Kanuma Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

kanuma

alexion europe sas - sebelipasa alfa - lipid efnaskipti, innfelldar villur - Önnur meltingarvegi og efnaskipti vörur, - kanuma er ætlað til langtímameðferð með ensímuppbótarmeðferð (ert) hjá sjúklingum á öllum aldri, með skort á lysósölt sýru lípasa (lal).

Cutaquig Stungulyf, lausn 165 mg/ml Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

cutaquig stungulyf, lausn 165 mg/ml

octapharma ab - immunoglobulinum humanum inn - stungulyf, lausn - 165 mg/ml

Librela Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

librela

zoetis belgium - bedinvetmab - verkjalyf - hundar - for the alleviation of pain associated with osteoarthritis in dogs.

Solensia Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

solensia

zoetis belgium sa - frunevetmab - verkjalyf - kettir - for the alleviation of pain associated with osteoarthritis in cats.